Latest news
NeuroThera Launches Phase IIb Trial at Yale for Novel Tourette Treatment - citybuzz -citybuzz - · Thu, 06 Aug 2026 00:24:05 GMTSciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock TitanStock Titan · Wed, 05 Aug 2026 13:00:51 GMTNeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-Its-Kind Treatment for Tourette Syndrome - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:48:44 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock TitanStock Titan · Wed, 05 Aug 2026 12:22:00 GMTNeuroThera starts Phase IIb trial of SCI-110 fo... - PluangPluang · Wed, 05 Aug 2026 07:00:00 GMT